A Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced Solid Tumors

Clinical trial NCT06796699 · RECRUITING

Trial details

NCT number: NCT06796699
Sponsor: Suzhou Genhouse Bio Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors With MTAP Gene Deletion

Start date: 2025-03-07
Primary completion: 2027-12-31
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.